Emcure Pharmaceuticals Limited (BOM:544210)

Market Cap	203.15B
Revenue (ttm)	75.51B
Net Income (ttm)	6.08B
Shares Out	n/a
EPS (ttm)	32.85
PE Ratio	33.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,480
Average Volume	39,403
Open	1,025.50
Previous Close	1,024.65
Day's Range	1,008.05 - 1,054.35
52-Week Range	911.75 - 1,577.50
Beta	n/a
RSI	58.05
Earnings Date	May 27, 2025

About Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral mol...

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 10,852
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544210

Financial Performance

In 2023, Emcure Pharmaceuticals's revenue was 66.58 billion, an increase of 11.23% compared to the previous year's 59.86 billion. Earnings were 4.98 billion, a decrease of -6.36%.